SERA 3.19 (+1.92%)
US81749D1072• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. SERA

Sera Prognostics (SERA) Competitor Comparison

We are evaluating the key criteria listed to compare Sera Prognostics (SERA) against its competitors in the Diagnostics & Research industry.

Market Capitalization

39 / 58

Gross Profits

51 / 52

Total Revenue

54 / 57

EBITDA

43 / 56

Free Cashflow

41 / 56

Quick Ratio

21 / 57

Earnings per Share

36 / 56

Dividend yield

0 / 9

Total Cash

40 / 57

Performance 3 years

13 / 58

Performance 5 years

46 / 58

Performance 10 years

42 / 58

Linearity 3 years

3 / 58

Linearity 5 years

43 / 58

Linearity 10 years

28 / 58

Total Rank

49 / 58

Dividend Rank

33 / 58

Valuation Rank

46 / 58

Piotroski Rank

45 / 58

Muliplier Rank

33 / 58

Performance 3 years - SERA ranking 13 / 58

These are the competitors of Sera Prognostics in the industry Diagnostics & Research ranked by performance 3 years
1. Meridian Bioscience VIVO
246.63
2. Natera NTRA
210.68
3. RadNet RDNT
116.06
4. Medpace Holdings MEDP
70.64
5. Lantheus Holdings LNTH
58.45
6. Heska HSKA
41.31
7. Quest Diagnostics DGX
21.98
8. PerkinElmer PKI
21.19
9. Ortho Clinical Diagnostics Holdings OCDX
13.74
10. Waters WAT
5.25
11. Laboratory Corp of America Holdings LH
-0.5
12. Anixa Biosciences ANIX
-9.96
13. Sera Prognostics SERA
-12.6
14. Syneos Health SYNH
-19.01
15. Olink Holding OLK
-22.2
16. Qiagen QGEN
-22.71
17. Agilent Technologies A
-23.05
18. Mettler-Toledo MTD
-25.28
19. Bioventus BVS
-25.69
20. Thermo Fisher Scientific TMO
-25.94
21. IDEXX Laboratories IDXX
-28.86
22. NeoGenomics NEO
-29.36
23. Danaher DHR
-29.84
24. Twist Bioscience TWST
-32.49
25. IQVIA Holdings IQV
-35.63
26. Icon ICLR
-37.94
27. Exact Sciences EXAS
-43.84
28. Guardant Health GH
-45.01
29. Exagen XGN
-48.33
30. Charles River Laboratories CRL
-52.56
31. Sotera Health SHC
-52.83
32. DexCom DXCM
-54.89
33. CareDx CDNA
-56.08
34. Personalis PSNL
-63.92
35. MaxCyte MXCT
-64.44
36. Psychemedics PMD
-64.82
37. Global Cord Blood CO
-67.25
38. Myriad Genetics MYGN
-68.77
39. National Research NRC
-69.26
40. Enzo Biochem ENZ
-70.36
41. Biodesix BDSX
-72.97
42. Fulgent Genetics FLGT
-73.17
43. Neogen NEOG
-75.18
44. Illumina ILMN
-79.08
45. Precipio PRPO
-81.18
46. MDxHealth MDXH
-82.1
47. Pacific Biosciences of California PACB
-87.08
48. bioAffinity Technologies BIAF
-88.45
49. Co-Diagnostics CODX
-88.94
50. Trinity Biotech TRIB
-89.06
51. Organovo Holdings ONVO
-89.19
52. Interpace Biosciences IDXG
-89.51
53. Inotiv NOTV
-90.54
54. Neuronetics STIM
-91.07
55. DarioHealth DRIO
-93.77
56. SeqLL SQL
-95.69
57. Prenetics Global PRE
-96.72
58. Aspira Womens Health AWH
-98.83
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.